Jugdutt B I, Khan M I, Jugdutt S J, Blinston G E
Department of Medicine, University of Alberta, Edmonton, Canada.
J Am Coll Cardiol. 1995 Apr;25(5):1089-96. doi: 10.1016/0735-1097(94)00531-t.
We sought to compare the effects of captopril plus isosorbide dinitrate versus monotherapy on infarct collagen content and left ventricular remodeling and function during healing after myocardial infarction.
Captopril or isosorbide dinitrate monotherapy can limit postinfarction dilation. Whether captopril inhibits infarct collagen content, or whether captopril plus isosorbide dinitrate might be more beneficial, is not known.
In vivo remodeling variables and function (echocardiography), hemodynamic variables, postmortem topography (planimetry) and collagen content (hydroxyproline) were measured in 48 chronically instrumented dogs that were randomized 2 days after left anterior descending coronary artery ligation to 6 weeks of therapy with captopril, isosorbide dinitrate, captopril plus isosorbide dinitrate or placebo.
Compared with placebo, the three active therapies decreased blood pressure and left atrial pressure; limited infarct expansion, infarct thinning, noninfarct wall stretching and thickening; limited left ventricular dilation and increase in left ventricular mass; and decreased regional bulging, aneurysm frequency and left ventricular dysfunction. However, the decrease in asynergy and increase in volume ejection fraction were less with captopril or captopril plus isosorbide dinitrate than with isosorbide dinitrate. Infarct thinning and bulging at 6 weeks was also less with isosorbide dinitrate than with captopril. Although initial left ventricular asynergy, final scar sizes and noninfarct collagen content at 6 weeks were similar among the groups, collagen in the center of the infarct scar was less with captopril or captopril plus isosorbide dinitrate than with placebo or isosorbide dinitrate.
Monotherapy with captopril or isosorbide dinitrate, or their combination, improved all remodeling variables, but isosorbide dinitrate improved function more than captopril or captopril plus isosorbide dinitrate. Inhibition of infarct collagen content by captopril suggests that benefits with captopril represent a balance between positive and negative effects, and its combination with isosorbide dinitrate might be advantageous.
我们试图比较卡托普利加硝酸异山梨酯与单一疗法对心肌梗死后愈合过程中梗死区胶原含量、左心室重构及功能的影响。
卡托普利或硝酸异山梨酯单一疗法可限制梗死后扩张。卡托普利是否抑制梗死区胶原含量,或者卡托普利加硝酸异山梨酯是否更有益,尚不清楚。
对48只长期植入仪器的犬进行测量,这些犬在左冠状动脉前降支结扎2天后随机分为四组,分别接受卡托普利、硝酸异山梨酯、卡托普利加硝酸异山梨酯或安慰剂治疗6周,测量其体内重构变量和功能(超声心动图)、血流动力学变量、尸检形态(平面测量)及胶原含量(羟脯氨酸)。
与安慰剂相比,三种活性治疗均降低了血压和左心房压力;限制了梗死区扩张、梗死区变薄、非梗死心肌壁伸展和增厚;限制了左心室扩张和左心室质量增加;并减少了局部膨出、动脉瘤发生率和左心室功能障碍。然而,与硝酸异山梨酯相比,卡托普利或卡托普利加硝酸异山梨酯在减少心肌运动不协调和增加射血分数方面作用较小。硝酸异山梨酯在6周时导致的梗死区变薄和膨出也比卡托普利少。尽管各组之间最初的左心室心肌运动不协调、最终的瘢痕大小及6周时的非梗死区胶原含量相似,但卡托普利或卡托普利加硝酸异山梨酯组梗死瘢痕中心的胶原比安慰剂组或硝酸异山梨酯组少。
卡托普利或硝酸异山梨酯单一疗法,或二者联合应用,均可改善所有重构变量,但硝酸异山梨酯在改善功能方面比卡托普利或卡托普利加硝酸异山梨酯更有效。卡托普利对梗死区胶原含量的抑制作用表明,卡托普利的益处是正负效应之间的平衡,其与硝酸异山梨酯联合应用可能更具优势。